Like what you read? Get new posts delivered straight to your inbox!
Contact Us | Follow Us
Experience. Integrity. IMPACT.
What We Do

Kathryn Tworkoski, PhD, RAC Promoted to Senior Clinical Research Scientist

RESEARCH TRIANGLE PARK, NC: 27 Mar 2018 – In March 2018, Kathryn Tworkoski, PhD, RAC was promoted to the position of Senior Clinical Research Scientist at Impact Pharmaceutical Services, Inc. (IMPACT).

Kathryn joined the IMPACT family in November of 2014 as a Clinical Research Scientist. During her time at IMPACT, Kathryn has served as a writer in our early phase group, as well as for multiple NDA/BLA submissions, and has earned her Regulatory Affairs Certification (RAC). She has been lead writer on a diverse array of complex documents, including INDs, CSRs, IBs, protocols, narratives, submission summary documents, manuscripts, and IMPACT blog posts, across a wide range of therapeutic areas. Kathryn has consistently received positive feedback for the quality of her work and critical assessment of data both internally from her IMPACT colleagues and externally from Sponsors. She has also become a mentor and reviewer to junior writers and has always been willing to lend a helping hand to her colleagues whenever needed.

“It has been really exciting to watch Kathryn develop as an outstanding regulatory medical writer and project manager during her time thus far at IMPACT,” said Elaina Howard, IMPACT Senior Manager. “Kathryn’s promotion to Senior Clinical Research Scientist is very well deserved and is reflective of the fact that she has become a trusted resource for her colleagues and Sponsor teams alike. Kathryn quickly gained a reputation for delivering extremely high quality documents with a level of critical thinking that is truly remarkable. She also displays strong mentorship and project management skills on a daily basis. She is an integral member of the IMPACT family!”

Tim Garver, IMPACT COO, adds “Since joining IMPACT in November of 2014, Kathryn quickly established herself to be an extremely talented medical writer and drug development professional. In addition, Kathryn positively contributes to our valued work culture here at IMPACT via both her collaborative spirit and sense of humor. We are lucky to have Kathryn, and this promotion reflects both her professional talents as well as all that she brings to the IMPACT family and culture.”

IMPACT is a Contract Research Organization (CRO) located in Research Triangle Park, NC. Our team consists of drug development professionals who specialize in medical writing and quality control, drug development consulting, regulatory affairs, regulatory operations, project and program management, and early phase clinical trial management.

Media Contact:

Mark A. Cierpial, PhD, Chief Executive Officer
Phone: (919) 899-9248
Fax: (919) 354-6090
mcierpial@impactpharma.com
www.impactpharma.com

6